Instituto de Investigaciones Biomédicas Alberto Sols-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2014

  1. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition

    Journal of Pathology, Vol. 232, Núm. 3, pp. 319-329

2012

  1. The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells

    Oncogene, Vol. 31, Núm. 16, pp. 2049-2061

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

2009

  1. Functional characterization of E- and P-cadherin in invasive breast cancer cells

    BMC Cancer, Vol. 9

  2. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: A molecular study of 29 cases

    American Journal of Surgical Pathology, Vol. 33, Núm. 8, pp. 1157-1163

2008

  1. "New" molecular taxonomy in breast cancer

    Clinical and Translational Oncology, Vol. 10, Núm. 12, pp. 777-785

  2. Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer

    Proteomics - Clinical Applications, Vol. 2, Núm. 9, pp. 1313-1326

  3. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen

    Modern Pathology, Vol. 21, Núm. 8, pp. 925-936

  4. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

    Cancer Research, Vol. 68, Núm. 4, pp. 989-997

  5. PAI-1 and functional blockade of SNAI1 in breast cancer cell migration

    Breast Cancer Research, Vol. 10, Núm. 6

2007

  1. Inhibition of paclitaxel-induced proteasome activation influences paclitaxel cytotoxicity in breast cancer cells in a sequence-dependent manner

    Cell Cycle, Vol. 6, Núm. 21, pp. 2662-2668

  2. Molecular profiling of docetaxel cytotoxicity in breast cancer cells: Uncoupling of aberrant mitosis and apoptosis

    Oncogene, Vol. 26, Núm. 20, pp. 2902-2913

  3. Telling cells how to die: Docetaxel therapy in cancer cell lines

    Cell Cycle, Vol. 6, Núm. 7, pp. 780-783

2006

  1. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, Slug, and E47 Factors in epithelial- mesenchymal transition

    Cancer Research, Vol. 66, Núm. 19, pp. 9543-9556

  2. Role of c-Src in human MCF7 breast cancer cell tumorigenesis

    Journal of Biological Chemistry, Vol. 281, Núm. 30, pp. 20851-20864

2004

  1. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions

    Oncogene, Vol. 23, Núm. 19, pp. 3272-3283

2003

  1. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: Comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases

    European Urology, Vol. 43, Núm. 4, pp. 342-350

2002

  1. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

    Oncogene, Vol. 21, Núm. 20, pp. 3241-3246

1996

  1. Expression pattern of the cell adhesion molecules E-cadherin, P-cadherin and α6β4 integrin is altered in pre-malignant skin tumors of p53-deficient mice

    International Journal of Cancer, Vol. 65, Núm. 2, pp. 254-262

1995

  1. The status of NF1-GRD mutation and p53 expression in neuroblastoma

    International Journal of Oncology, Vol. 7, Núm. 4, pp. 755-757